Chemical Name: 3-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylene]-1,3-dihydro-2H-indol-2-one
Biological ActivityInhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET. Displays no activity against EGFR, HER2, IGF1R and PDGFR. Inhibits tumor vascularization and growth of multiple tumor types.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularisation, and growth of multiple tumor types.
Fong et al.
Cancer Res., 1999;59:99
The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-Kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts.
Smolich et al.
Inhibition of RET tyrosine kinase by SU5416.
Mologni et al.
Citations for SU 5416
The citations listed below are publications that use Tocris products. Selected citations for SU 5416 include:
12 Citations: Showing 1 - 10
Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H2S Production.
Authors: Longchamp Et al.
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Nat Commun 2017;8:14079
Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension.
Authors: Meloche Et al.
Arterioscler Thromb Vasc Biol 2017;37:1513
Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition.
Authors: Neto-Neves Et al.
Am J Pathol 2017;187:700
Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.
Authors: Happé Et al.
Am J Physiol Lung Cell Mol Physiol 2016;310:L1088
Desert Hedgehog/Patch2 Axis Contributes to Vascular Permeability and Angiogenesis in Glioblastoma.
Authors: Azzi Et al.
Pulm Circ 2015;6:281
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
Authors: Long Et al.
Nat Med 2015;21:777
Role of vascular endothelial growth factor signaling in Schistosoma-induced experimental pulmonary hypertension.
Authors: Chabon Et al.
J Neurophysiol 2014;4:289
KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.
Authors: DiStefano Et al.
J Biol Chem 2014;289:33054
Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.
Authors: Hempel Et al.
Malar J 2014;13:201
Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.
Authors: Cavasin Et al.
J Transl Med 2014;12:314
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cells.
Authors: Novitskiy Et al.
J Thorac Oncol 2010;5:1410
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
VersaClone cDNA Plasmids
Reviews for SU 5416
Average Rating: 5 (Based on 1 Review)
Have you used SU 5416?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
We study rodent models of pulmonary hypertension where we inject SU5416 in addition to placing the animals in hypoxia to exacerbate the PH phenotype